Description

This Exchange-Traded Fund (ETF) employs a passive management strategy, with its primary goal being to replicate the comprehensive total return performance of the NASDAQ Biotechnology Index. Investors should note that their net returns will be calculated after the deduction of management fees, operational expenses, and transaction costs.